Vicapsys Life Sciences annual ebitda
2021
2022
2023
Vicapsys Life Sciences EBITDA Growth & History (VICP)
Vicapsys Life Sciences's calculated EBITDA was −$1.2M for fiscal 2023.
View full Vicapsys Life Sciences company overviewVicapsys Life Sciences annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | −$1.2M | −$208,642 | — |
| 2022 | 2022-12-31 | −$953,501 | −$647,959 | — |
| 2021 | 2021-12-31 | −$305,542 | — | — |
Vicapsys Life Sciences ebitda trends
Between the periods ended 2021-12-31 and 2023-12-31, Vicapsys Life Sciences's ebitda decreased from −$305,542 to −$1.2M, a change of −$856,601.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vicapsys Life Sciences source filings ↗